SCHEMBL2647017

SCHEMBL2647017

CCCCC/C=C/c1c(C(C)C)nc(C(C)C)c(CO)c1-c1ccc(F)cc1

nearest known ligand 0.68

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GCGR P47871 20/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2647020 1.00 GCGR (0.68) GCGR
SCHEMBL2648490 0.99 GCGR (0.67) GCGR
SCHEMBL2648380 0.99 GCGR (0.67) GCGR
SCHEMBL2648333 0.97 GCGR (0.69) GCGR
SCHEMBL2648332 0.97 GCGR (0.69) GCGR
SCHEMBL2647428 0.92 GCGR (0.72) GCGR
SCHEMBL2647431 0.92 GCGR (0.72) GCGR
SCHEMBL2647852 0.88 GCGR (0.76) GCGR
SCHEMBL2647853 0.88 GCGR (0.76) GCGR
SCHEMBL22927105 0.87 GCGR (0.57) GCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218431-B1 GLUCAGON RECEPTOR ANTAGONISTS FOR THERAPY OF DIABETES AND CONDITIONS ASSOCIATED WITH DIABETES BAYER CORPORATION 2001-04-17 US disclosed
EP-0934274-A1 SUBSTITUTED PYRIDINES AND BIPHENYLS AS ANTI-HYPERCHOLESTERINEMIC, ANTI-HYPERLIPOPROTEINEMIC AND ANTI-HYPERGLYCEMIC AGENTS Bayer Corporation (US) 1999-08-11 EP disclosed
WO-1998004528-A2 SUBSTITUTED PYRIDINES AND BIPHENYLS AS ANTI-HYPERCHOLESTERINEMIC, ANTI-HYPERLIPOPROTEINEMIC AND ANTI-HYPERGLYCEMIC AGENTS BAYER CORPORATION (US) 1998-02-05 WO disclosed